Ticker LaunchIPO · CNTG
Centogene N.V.
Formerly Centogene B.V.
Centogene N.V. (CNTG) priced its initial public offering on Nov 8, 2019 at $14.00 per share, within its $14.00–$16.00 range, raising $56M, and listed on Nasdaq Global Market. At the IPO price its market capitalization was about $278.1M. Davis Polk advised the company and Goodwin Procter and Freshfields advised the underwriters.
Centogene N.V. is a commercial-stage company focused on rare diseases that turns real-world clinical and genetic data into information for patients, physicians and pharmaceutical companies. Its platform draws on a data repository from over 450,000 patients in 115 countries and a biobank of blood samples.
- Status
- IPO
- Ticker
- CNTG
- Exchange
- Nasdaq Global Market
- Priced
- Nov 8, 2019
- IPO price
- $14.00
- Price range
- $14.00–$16.00
- Raised
- $56M
- Market cap at IPO price
- $278.1M
- First filed
- Oct 11, 2019
- Company counsel
- Davis Polk
- Underwriters' counsel
- Goodwin Procter and Freshfields
- Sector
- Healthcare
- Country / state
- Germany
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (F-1) first filed Oct 11, 2019
- Latest amendment Oct 28, 2019
- Final prospectus (424B4) Nov 8, 2019
- All filings on EDGAR CIK 1757097
Other Healthcare IPOs in 2019
- TELA Bio, Inc.TELA · Nov 8, 2019 · $52M
- Aesthetic Medical International Holdings Group LtdAIH · Oct 25, 2019 · $30M
- Progyny, Inc.PGNY · Oct 25, 2019 · $130M
- Exagen Inc.XGN · Sep 20, 2019 · $50.4M
- Envista Holdings CorpNVST · Sep 19, 2019 · $588.9M
- SmileDirectClub, Inc.SDC · Sep 13, 2019 · $1.35B